Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica»-Reference-Cited by-同舟云学术

Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica»

Published:2021-10 Issue: Volume: Page:
ISSN:0001-7310
Container-title:Actas Dermo-Sifiliográficas
language:es
Short-container-title:Actas Dermo-Sifiliográficas

Author:

Carrascosa J.M.,Puig L.,Belinchón Romero I.,Salgado-Boquete L.,del Alcázar E.,Andrés Lencina J.J.,Moreno D.,de la Cueva P.

Publisher

Elsevier BV

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference155 articles.

1. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology;Dauden;J Eur Acad Dermatol Venereol.,2016

2. Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: On efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology;Puig;Actas Dermosifiliogr.,2013

3. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology];Puig;Actas Dermosifiliogr.,2009

4. Biosimilar and interchangeable: Inseparable scientific concepts?;De Mora;Br J Clin Pharmacol.,2019

5. Biosimilars in Dermatology: Current situation (Part I);Puig;Actas Dermosifiliogr.,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calidad de vida percibida por los pacientes con psoriasis tratados con inhibidores de interleucina 17 y 23;Farmacia Hospitalaria;2024-09

2. [Translated article] Perceived quality of life in patients with psoriasis treated with interleukin 17 or 23 inhibitors;Farmacia Hospitalaria;2024-09

3. Experiencia en la práctica clínica tras la optimización de la dosis del secukinumab en la psoriasis moderada-severa. Serie retrospectiva de 11 casos;Actas Dermo-Sifiliográficas;2024-09

4. [Translated article] Study of the Impact of Restrictions on Access to Biological Drugs for the Management of Psoriasis on the Minimum Disease Activity Criteria: Subanalysis of AEDV EQUIDAD and AME Projects;Actas Dermo-Sifiliográficas;2024-08

5. A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study;Dermatology;2024-07-17